ASTERDM
Aster DM Healthcare Limited (ASTERDM) Stock Analysis
Aster DM Healthcare Limited operates hospitals and clinics in India and the Gulf region. It provides multi-specialty healthcare services under the Aster brand with a strong Kerala and Middle East presence. The company is among the larger listed hospital chains with international operations. It is a listed healthcare stock.
Healthcare › Medical Care Facilities
₹674.40
-3.64% 1W | -2.80% 52W
Market Cap
58.8k CR
P/E Ratio
109.3
52W High
₹891.3
52W Low
₹519.1
Div. Yield
0.44%
Beta
-0.1
50 DMA
₹757.4
200 DMA
₹714.5
Profit Margin
6.5%
Inst. Own.
21.1%
⚠️ BREAKDOWN
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 841 | 929 | 955 | 974 | 1,002 | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 |
| Expenses | 722 | 787 | 805 | 817 | 841 | 869 | 864 | 818 | 876 | 961 | 983 | 958 | 1,055 |
| Operating Profit | 119 | 142 | 149 | 156 | 161 | 217 | 186 | 182 | 202 | 236 | 202 | 224 | 256 |
| OPM % | 14% | 15% | 16% | 16% | 16% | 20% | 18% | 18% | 19% | 20% | 17% | 19% | 20% |
| Other Income | -17 | -64 | 153 | -40 | 5,120 | 35 | 9 | 5 | 29 | 28 | -0 | 37 | -77 |
| Interest | 25 | 30 | 25 | 30 | 29 | 31 | 31 | 32 | 31 | 31 | 31 | 30 | 31 |
| Depreciation | 51 | 54 | 57 | 58 | 60 | 62 | 62 | 64 | 63 | 66 | 68 | 67 | 69 |
| Profit before tax | 26 | -7 | 220 | 28 | 5,191 | 159 | 102 | 91 | 136 | 167 | 103 | 163 | 78 |
| Tax % | 24% | 120% | 5% | 108% | 1% | 33% | 37% | 6% | 31% | 27% | 43% | 6% | 62% |
| Net Profit | 20 | -15 | 209 | -2 | 5,152 | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 |
| EPS in Rs | 0.10 | -0.62 | 3.59 | -0.48 | 103.00 | 1.94 | 1.14 | 1.58 | 1.65 | 2.12 | 1.01 | 2.71 | 0.31 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,876 | 5,250 | 5,931 | 6,721 | 7,963 | 8,652 | 8,608 | 10,253 | 2,994 | 3,699 | 4,138 | 4,643 | 4,876 |
| Expenses | 3,370 | 4,805 | 5,582 | 6,089 | 6,886 | 7,187 | 7,506 | 8,720 | 2,547 | 3,124 | 3,383 | 3,769 | 3,958 |
| Operating Profit | 506 | 445 | 349 | 632 | 1,077 | 1,465 | 1,103 | 1,533 | 447 | 575 | 756 | 875 | 918 |
| OPM % | 13% | 8% | 6% | 9% | 14% | 17% | 13% | 15% | 15% | 16% | 18% | 19% | 19% |
| Other Income | 23 | 25 | 453 | 177 | -155 | -158 | 53 | 51 | 353 | 32 | 5,168 | 91 | -13 |
| Interest | 79 | 189 | 371 | 204 | 205 | 391 | 334 | 307 | 96 | 119 | 133 | 132 | 123 |
| Depreciation | 144 | 243 | 322 | 298 | 306 | 586 | 618 | 641 | 192 | 220 | 249 | 264 | 270 |
| Profit before tax | 306 | 38 | 108 | 308 | 410 | 330 | 205 | 637 | 511 | 268 | 5,542 | 570 | 511 |
| Tax % | 11% | 78% | 10% | 8% | 10% | 5% | 13% | 6% | 7% | 21% | 2% | 25% | |
| Net Profit | 272 | 8 | 98 | 282 | 367 | 315 | 178 | 601 | 475 | 212 | 5,408 | 427 | 363 |
| EPS in Rs | 7.00 | 0.20 | 2.52 | 5.32 | 6.59 | 5.54 | 2.96 | 10.53 | 8.51 | 2.59 | 107.66 | 7.49 | 6.15 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 4,637% | 5% | 40% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 16.0% | -12.0% | -1.0% |
| Profit CAGR | -1.0% | 23.0% | 48.0% |
Shareholding Pattern
Promoters40.39%
FIIs18.72%
DIIs26.32%
Public14.33%
Promoters40.39%
FIIs18.46%
DIIs26.12%
Public14.80%
Promoters40.39%
FIIs17.18%
DIIs27.57%
Public14.61%
Promoters40.39%
FIIs10.53%
DIIs27.65%
Public21.41%
Promoters53.72%
FIIs10.32%
DIIs16.48%
Public19.48%
Promoters41.88%
FIIs38.63%
DIIs8.93%
Public10.12%
Promoters41.88%
FIIs33.48%
DIIs13.70%
Public10.59%
Promoters41.89%
FIIs21.66%
DIIs24.58%
Public11.60%
Promoters40.39%
FIIs17.18%
DIIs27.57%
Public14.61%
Promoters53.72%
FIIs10.32%
DIIs16.48%
Public19.48%
ASTERDM
Holdings Analysis
Key strengths & risk signals
56
Overall
58
Fundamental
55
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
WEAK POSITION! Current price (674.4) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.6% (1 week), 9.0% (1 month), 17.8% (3 months).
WEAK YEAR! Stock declined 2.8% in the last year.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (757.4) is above 200-day average (714.5) - positive signal.
LOW VOLATILITY! Beta of -0.10 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 35.1 - watch for reversal.
Fundamental & Technical Analysis
56Overall
58Fundamental
55Technical
Fundamental Breakdown
Growth Quality
15/30
Revenue CAGR: 15.7% (VERY GOOD, 13/15). Profit CAGR: -3.0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 6.5% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0.44% yield - little to no income.
Debt to Equity
6/10
MODERATE DEBT! D/E of 0.55 - acceptable leverage.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 10.26% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (757.4) is above 200-day average (714.5) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (674.4) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
3/10
WEAK YEAR! Stock declined 2.8% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 1,184,250 vs down days: 1,271,903. Ratio: 0.93x
RSI
4/5
APPROACHING OVERSOLD! RSI at 35.1 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 41.7% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.6% (1 week), 9.0% (1 month), 17.8% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of -0.10 - stable stock, less market risk.
ASTERDM
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-10-14 | Concall PDF | |
| Q4FY262026-05-08 | Concall PDF | |
| Q3FY262026-02-09 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASTERDM | ₹674.40 | 109.3 | 6.5% | 15.7% | -3.0% | -2.8% | 56 | BREAKDOWN | -81.2% | -88.5% | +21.6% | +10.9% |
| FORTIS | ₹736.50 | 53.1 | 11.0% | 13.3% | 21.0% | -31.2% | 61 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| MAXHEALTH | ₹846.00 | 56.7 | 16.7% | 22.4% | 9.3% | -28.7% | 55 | BREAKDOWN | +4.9% | -5.6% | +16.7% | +10.4% |
| NH | ₹1,719.40 | 42.5 | 9.0% | 20.5% | 9.9% | -3.8% | 59 | APPROACHING SUPPORT | +5.3% | -7.5% | +78.0% | +3.5% |
| MEDANTA | ₹1,240.00 | 60 | 11.9% | 17.2% | 19.5% | -6.7% | 64 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| APOLLOHOSP | ₹7,890.00 | 54.3 | 7.9% | 14.8% | 33.3% | -0.2% | 63 | BREAKDOWN | +34.2% | +9.7% | +20.6% | +6.6% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
ASTERDM News
Aster DM Quality Care Limited (asterdm) Dr. Moopen Family Increases Stake by ~₹350 Crore2026-09-04Aster DM Quality Care Limited Q1 FY27 Earnings Presentation: Revenue Up 20%, PAT Rises 15%2026-08-05Aster DM Healthcare Limited Launches Aster Quality Care to Expand Advanced Healthcare Nationwide2026-07-02
